What is claimed is:
1. An instrument for treating surface layers of a patient’s skin, comprising:
a hand-held instrument having a working end that defines a working surface;
an abrasive fragment composition carried within the working surface for cutting skin surface layers;
wherein the working surface is of a partially floating flexible member that is capable of flexing proximally and distally; and
cooperating fluid inflow and fluid outflow apertures in the working surface.
2. The instrument of claim 1 further including a negative pressurization source in fluid communication with the outflow aperture.
3. The instrument of claim 1 further including a fluid source in fluid communication with the inflow aperture.
4. The working end of claim 1 wherein the abrasive fragment composition comprises diamond fragments.
5. The working end of claim 1 wherein the abrasive fragment composition comprises sharp-edged fragments having a cross-sectional dimension ranging from about 10 microns to 250 microns.
6. A system for treating surface layers of a patient’s skin, comprising:
(a) an instrument body with a distal working surface for engaging a skin surface;
(b) the working surface having partly a flexible floating wall member for conforming to skin topography;
(c ) an abrasive fragment composition carried in the working surface;
(d) at least one inflow aperture in said skin interface in fluid communication with a fluid reservoir; and
(e) at least one outflow aperture in said skin interface in communication with a negative pressurization source.
7. The system of claim 6 wherein the abrasive composition comprises diamond fragments.
8. The system of claim 6 wherein the at least one inflow apertures is located at a periphery of the working surface.
9. The system of claim 6 wherein the at least one outflow aperture is located generally centrally in the working surface.
10. A method for treating surface layers of a patient’s skin, comprising:
(a) providing an instrument with a partially floating working surface that carries an exposed abrasive fragment architecture;
(b) placing said floating working surface against a skin treatment site;
(c) actuating a negative pressurization source in fluid communication with at least one aperture in said working surface thereby drawing skin in contact with said abrasive fragment architecture;
(d) translating said floating working surface across the treatment site thereby cutting away surface layer portions; and
(e) wherein said working surface floatably maintains contact with the skin surface under the influence of negative pressurization between said working surface and the skin; and
11. The method of claim 10 wherein contemporaneous with steps (c) through (e) the additional step of flowing a fluid generally about the working surface between at least one inflow and outflow aperture therein the influence of said negative pressurization.
12. The method of claim 10 wherein in step (d), the removal of the skin surface layers induces neocollagenesis in the patient’s skin.
13. The method of claim 10 wherein neocollagenesis in the, patient’s skin reduces wrinkles.
14. The method of claim 10 wherein the flow of fluid hydrates the patient’s skin.
15. The method of claim 10 wherein the flow of fluid reduces pain.
16. The method of claim 10 wherein the flow of fluid removes skin debris from the treatment site.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A networked system for enabling a mobile device and a computing system to determine a user’s likely success for disease treatment from a treatment provider by providing access to masked pangenetic data of said user by said computing system and enabling said user to accept or reject a treatment provider, comprising:
a) a receiving interface in said mobile device enabling receiving a request from said computing system requiring access to at least a portion of pangenetic data of said user stored on said mobile device;
b) an authorization interface actuated by said user granting access to said at least a portion the pangenetic data of said user by generating an authorization associated with at least one pre-approved data mask and creating masked pangenetic data associated with said user; and
c) a transmission interface transmitting said masked pangenetic data associated with said user to said computing system; and,
d) said computing system conducting a comparative assessment of said masked pangenetic data associated with said user with previously stored treatment provider related data on said computing system to determine likely outcomes or success rates of said user with said treatment provider and providing said success rates to said user based on prior success rates of treatment of prior users of said treatment with correlated degrees of pangenetic data match of said user.
2. The networked system of claim 1, wherein the pangenetic data are selected from the group consisting of single nucleotide polymorphisms, nucleotides, base pairs, nucleotide sequences, gene sequences, genomic sequences, gene mutations, epigenetic modifications, epigenetic sequence patterns, and pangenetic based disorders, traits and conditions.
3. The networked system of claim 1 wherein the comparative assessment includes a recommendation for said user based on likely outcomes or success rates.
4. The networked system of claim 1 wherein said receiving interface, said authorization interface, and said transmission interface are contained within an application for said mobile device.
5. A computer based method for providing access to masked data of a user in a mobile environment to provide said user with data as to the likelihood of a useful therapeutic relationship being possible with respect to said user and a therapy provider, comprising:
a) transmitting a request from a second computer having therapy data stored therein to a mobile computer or processor, wherein the request includes requiring access to pangenetic data of said user stored on said mobile computer or processor;
b) receiving at least a portion of said user’s pangenetic information, wherein said at least a portion of said user’s pangenetic information is created from the application of at least one data mask; and
d) conducting a comparative assessment of said at least a portion of said user’s pangenetic data with previously stored treatment provider related data on said second computer system to determine likely outcomes or success rates of said user with said treatment provider and providing said success rates to said user based on prior success rates of treatment of prior users of said treatment having correlated degrees of pangenetic data match with said user.
6. The computer based method of claim 5, wherein the pangenetic data are selected from the group consisting of single nucleotide polymorphisms, nucleotides, base pairs, nucleotide sequences, gene sequences, genomic sequences, gene mutations, epigenetic modifications, epigenetic sequence patterns, and pangenetic based disorders, traits and conditions.
7. The computer based method of claim 5 wherein the data mask is authorized by the user.
8. The computer based method of claim 5 wherein the comparative assessment includes a recommendation for said user based on likely outcomes or success rates.
9. A program storage device readable by a machine and containing a set of instructions which, when read by the machine, causes execution of a computer based method for providing access to masked data of a user in a mobile environment to provide said user with data as to the likelihood of a useful therapeutic relationship being possible with respect to said user and a therapy provider, comprising:
a) transmitting a request from a second computer having therapy data stored therein to a mobile computer or processor, wherein the request includes a request for access to at least a portion of pangenetic data of said user stored on said mobile computer or processor;
b) processing an authorization initiated by said user associated with at least one pre-approved data mask authorized by said user to grant access to said at least a portion of pangenetic data of said user by said second computer and receiving said at least a portion of pangenetic data of said user;
c) conducting a comparative assessment of said at least a portion of pangenetic data of said user with previously stored treatment provider related data on said second computer system to determine likely outcomes or success rates of said user with said treatment provider and providing said success rates to said user based on prior success rates of treatment of prior users of said treatment having correlated degrees of pangenetic data match with said user.
10. The computer based method of claim 9, wherein the pangenetic data are selected from the group consisting of single nucleotide polymorphisms, nucleotides, base pairs, nucleotide sequences, gene sequences, genomic sequences, gene mutations, epigenetic modifications, epigenetic sequence patterns, and pangenetic based disorders, traits and conditions.
11. The program storage device of claim 9 wherein the conducting a comparative assessment includes a recommendation for said user based on likely outcomes or success rates.